We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current PHGE market cap is 14.63M. The company's latest EPS is USD -1.4397 and P/E is -0.57.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -7.8M | -5.27M | -6.79M | -9.73M | -11.33M |
| Net Income | -7.91M | -5.49M | -17.33M | 4.47M | 9.64M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -22.21M | -30.26M | -35.46M | -27.22M | -25.35M |
| Net Income | -20.56M | -30.09M | -36.23M | -28.32M | -26.17M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 33.06M | 25.03M | 81.61M | 68.62M | 59.98M |
| Total Liabilities | 24.9M | 21.95M | 58.73M | 41.19M | 22.08M |
| Total Equity | 8.15M | 3.08M | -9.54M | 27.43M | 37.9M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 92.12M | 70.36M | 77.99M | 45.53M | 25.03M |
| Total Liabilities | 7.67M | 12.89M | 30.46M | 24.49M | 21.95M |
| Total Equity | 84.46M | 57.47M | 47.54M | 21.04M | 3.08M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -15.04M | -21.29M | -11.36M | -22.59M | -30.69M |
| Investing | 1.96M | 1.95M | 663k | 717k | 716k |
| Financing | 4.22M | 2.9M | 38.98M | 38.77M | 38.77M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -17.58M | -24.45M | -27.57M | -29.09M | -21.29M |
| Investing | 19.74M | -10.86M | 16.17M | -2.11M | 1.95M |
| Financing | 61.55M | 134k | 37.28M | 292k | 2.9M |
| Market Cap | 14.63M |
| Price to Earnings Ratio | -0.57 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 1 |
| Price to Book Ratio | 4.84 |
| Dividend Yield | - |
| Shares Outstanding | 18.18M |
| Average Volume (1 week) | 30.64k |
| Average Volume (1 Month) | 96.72k |
| 52 Week Change | -67.80% |
| 52 Week High | 8.55 |
| 52 Week Low | 0.48 |
| Spread (Intraday) | 0.04 (4.47%) |
| Company Name | BiomX Inc |
| Address |
850 new burton road dover, delaware 19904 |
| Website | https://www.biomx.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
